Skip to content
Back to TLX

Telix Pharmaceuticals Ltd

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
3
Purchases
3
Sales
0
Purchase value
$1.02M
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Darren Charlton SmithGroup Chief Financial Officer
4
Filed Sep 14, 2026Period of report Sep 7, 20260001628280-26-061944
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseSep 7, 2026
Ordinary SharesF1F22,071$9.656$20.00K13,992Direct
Filing footnotes · 2
  1. F1Represents shares purchased by the Reporting Person under the Employee Share Purchase Plan section of the Issuer's Equity Incentive Plan ("AU ESPP"), which shares were allocated on September 7, 2026, based on the Reporting Person's contributions to the AU ESPP from January 1, 2026 - June 30, 2026.
  2. F2Purchase price is recorded in Australian Dollars.
Open on SEC EDGAR
Christian BehrenbruchDirector · MD & Group CEO
4
Filed May 6, 2026Period of report Apr 28, 20260001628280-26-031608
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseApr 29, 2026
Ordinary SharesF2F4F333,435$14.87$497.18K20,742,935IndirectElk River Holdings Pty Ltd
PurchaseApr 28, 2026
Ordinary SharesF1F2F334,500$14.48$499.56K20,709,500IndirectElk River Holdings Pty Ltd
Filing footnotes · 4
  1. F1The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.42 - $14.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
  2. F2The purchase prices are reported in Australian Dollars.
  3. F3Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd.
  4. F4The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.54 - $14.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.